OPN1SW and COVID-19: The available studies are clearly suggestive of the therapeutic benefits of BCP in atherosclerosis, acute myocardial infarction, dyslipidemia, obesity, and fatty liver and could be important in preventing the worsening of the condition in COVID-19 patients.